查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1178516

分子诊断服务的全球市场:产业趋势与预测(～2030年)

Global Molecular Diagnostics Services Market - Industry Trends and Forecast to 2030
出版日期: | 出版商: Data Bridge Market Research | 英文 681 Pages | 商品交期: 请询问到货日

价格

全球分子诊断服务的市场规模，预计2023年～2030年的预测期间记录相当于7.9％的年复合成长率。

对检验、治疗、诊断的迅速化的需求增加，在分子诊断领域的资金筹措的扩大等，是市场成长的主要促进因素。

本报告提供全球分子诊断服务市场相关调查分析，市场概要，各市场区隔、各地区的市场分析，竞争分析，企业简介等系统性资讯。

目录

第1章 简介

第2章 市场明细

第3章 摘要整理

第4章 重要洞察

  • PESTEL分析
  • 波特的五力分析

第5章 市场概要

  • 促进因素
  • 阻碍因素
  • 机会
  • 课题

第6章 全球分子诊断服务市场:各服务形式

  • 概要
  • 设备维修服务
  • 维修服务
  • 培训
  • 校对服务
  • 遵守服务
  • 承包服务
  • 可伸缩自动化服务
  • 硬体设备客製化
  • 设备移设服务
  • 性能保证服务
  • 设计、开发服务
  • 供应链解决方案
  • 新产品引进服务
  • 製造服务
  • 环境、法规服务
  • 医疗管理系统认证、审核
  • 临床调查服务
  • 咨询服务
  • 其他服务

第7章 全球分子诊断服务市场:各技术

  • 概要
  • 即时PCR
  • PCR
  • 次世代定序
  • 其他技术

第8章 全球分子诊断服务市场:各终端用户

  • 概要
  • 医院
  • 诊断中心
  • 学术、研究机关
  • 其他

第9章 全球分子诊断服务市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 荷兰
    • 瑞士
    • 瑞典
    • 比利时
    • 挪威
    • 波兰
    • 丹麦
    • 土耳其
    • 芬兰
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 印度
    • 澳洲
    • 纽西兰
    • 印尼
    • 泰国
    • 越南
    • 新加坡
    • 菲律宾
    • 马来西亚
    • 台湾
    • 其他亚太地区
  • 南美
    • 巴西
    • 阿根廷
    • 其他南美
  • 中东、非洲
    • 南非
    • 沙乌地阿拉伯
    • 以色列
    • 埃及
    • 阿拉伯联合大公国
    • 科威特
    • 卡达
    • 阿曼
    • 巴林
    • 其他中东、非洲

第10章全球分子诊断服务市场:企业形势

  • 企业占有率分析:世界
  • 企业占有率分析:北美
  • 企业占有率分析:欧洲
  • 企业占有率分析:亚太地区

第11章 SWOT分析

第12章 企业简介

  • F.HOFFMANN-LA ROCHE LTD
  • DANAHER
  • BIOMERIEUX
  • QIAGEN
  • THERMO FISHER SCIENTIFIC
  • ABBOTT
  • BIO-RAD LABORATORIES, INC
  • DIASORIN
  • HOLOGIC, INC

第13章 问卷调查

第14章 相关报告

Global molecular diagnostics services market is projected to register a substantial CAGR of 7.9% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Global Molecular Diagnostics Services Market, By Service Type (Instrument Repair Services, Training Services, Compliance Services, Calibration Services, Maintenance Services, Scalable Automation Services, Turnkey Services, Instrument Relocation Services, Hardware Customization, Performance Assurance Services, Design and Development Services, Supply Chain Solutions, New Product Introduction Services, Manufacturing Services, Environmental & Regulatory Services, Medical Management Systems Certification & Auditing, Clinical Research Services, Consultative Services, and Other Services), Technology (PCR, Real Time PCR, Next Generation Sequencing, and Other Technologies), End User (Hospitals, Diagnostic Centers, Academic & Research Institutions, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Denmark, Switzerland, Turkey, Sweden, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Ethiopia, UAE, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the global molecular diagnostics services market are:

Increasing demand for testing, therapies, and faster diagnostics

Growing funding in the molecular diagnostics segment

Market Players

The key market players operating in the global molecular diagnostics services market are listed below:

F. Hoffmann-La Roche Ltd

Danaher

BIOMERIEUX

QIAGEN

Thermo Fisher Scientific

Bio-Rad Laboratories, Inc

Abbott

DiaSorin S.p.A

Hologic, Inc

TABLE OF CONTENTS

1 INTRODUCTION 54

  • 1.1 OBJECTIVES OF THE STUDY 54
  • 1.2 MARKET DEFINITION 54
  • 1.3 OVERVIEW OF GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET 54
  • 1.4 LIMITATIONS 56
  • 1.5 MARKETS COVERED 56

2 MARKET SEGMENTATION 62

  • 2.1 MARKETS COVERED 62
  • 2.2 GEOGRAPHICAL SCOPE 63
  • 2.3 YEARS CONSIDERED FOR THE STUDY 64
  • 2.4 CURRENCY AND PRICING 64
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 65
  • 2.6 MULTIVARIATE MODELLING 68
  • 2.7 SERVICE TYPE LIFELINE CURVE 68
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 69
  • 2.9 DBMR MARKET POSITION GRID 70
  • 2.10 MARKET END USER COVERAGE GRID 71
  • 2.11 VENDOR SHARE ANALYSIS 72
  • 2.12 SECONDARY SOURCES 73
  • 2.13 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

4 PREMIUM INSIGHTS 76

  • 4.1 PESTEL ANALYSIS 79
  • 4.2 PORTER'S FIVE FORCES 80

5 MARKET OVERVIEW 81

  • 5.1 DRIVERS 83
    • 5.1.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES 83
    • 5.1.2 INCREASING DEMAND FOR TESTING, THERAPIES, AND FASTER DIAGNOSTICS 83
    • 5.1.3 GROWING FUNDINGS IN MOLECULAR DIAGNOSTICS SEGMENT 83
  • 5.2 RESTRAINTS 84
    • 5.2.1 HIGH-COST ASSOCIATED WITH MOLECULAR DIAGNOSTICS LABS SET-UPS AND OTHER INSTRUMENTATIONS 84
    • 5.2.2 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS 84
  • 5.3 OPPORTUNITIES 85
    • 5.3.1 STRATEGIC INITIATIVES BY KEY PLAYERS 85
    • 5.3.2 RISING GOVERNMENT AND PRIVATE COLLABORATIONS 85
    • 5.3.3 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES 85
  • 5.4 CHALLENGES 86
    • 5.4.1 STRINGENT REGULATIONS 86
    • 5.4.2 LACK OF SKILLED PROFESSIONALS 86

6 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 88

  • 6.1 OVERVIEW 89
  • 6.2 INSTRUMENT REPAIR SERVICES 94
    • 6.2.1 ON-SITE REPAIR SERVICES 95
    • 6.2.1 OFF-SITE REPAIR SERVICES 95
  • 6.3 MAINTENANCE SERVICES 95
  • 6.4 TRAINING SERVICES 95
    • 6.4.1 PCR BASED MOLECULAR DIAGNOSTICS 96
    • 6.4.2 IMMUNOHISTOCHEMISTRY (IHC) 96
    • 6.4.3 VIRAL LOAD TESTING 97
    • 6.4.4 INTERPHASE CHROMOSOME PROFILING (ICP) 97
    • 6.4.5 APPLICATION TRAINING SERVICES 97
  • 6.5 CALIBRATION SERVICES 97
  • 6.6 COMPLIANCE SERVICES 98
    • 6.6.1 IQ/OQ & PM/OQ SERVICES 99
    • 6.6.2 INSTALLATION SERVICES 99
    • 6.6.3 VALIDATION SERVICES 99
    • 6.6.4 OTHER SERVICES 99
  • 6.7 TURNKEY SERVICES 99
  • 6.8 SCALABLE AUTOMATION SERVICES 100
    • 6.8.1 AUTOMATION FOR HIGH-CONTENT SCREENING (HCS) 101
    • 6.8.2 AUTOMATION FOR HIGH-THROUGHPUT PLATE-BASED ASSAYS 101
    • 6.8.3 AUTOMATION FOR HIGH-THROUGHPUT CLONE SCREENING 101
  • 6.9 HARDWARE CUSTOMIZATION 102
  • 6.10 INSTRUMENT RELOCATION SERVICES 102
    • 6.10.1 PLATE RECERTIFICATION 103
    • 6.10.2 FACTORY-APPROVED PARTS 103
    • 6.10.3 INSTRUMENT PERFORMANCE EVALUATION 103
    • 6.10.4 OTHER SERVICES 104
  • 6.11 PERFORMANCE ASSURANCE SERVICES 104
  • 6.12 DESIGN AND DEVELOPMENT SERVICES 104
  • 6.13 SUPPLY CHAIN SOLUTIONS 105
  • 6.14 NEW PRODUCT INTRODUCTION SERVICES 106
  • 6.15 MANUFACTURING SERVICES 107
  • 6.16 ENVIRONMENTAL AND REGULATORY SERVICES 107
  • 6.17 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING 108
  • 6.18 CLINICAL RESEARCH SERVICES 109
  • 6.19 CONSULTATIVE SERVICES 109
  • 6.20 OTHER SERVICES 110

7 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY 111

  • 7.1 OVERVIEW 112
  • 7.2 REAL TIME PCR 114
    • 7.2.1 INSTRUMENT REPAIR SERVICES 117
    • 7.2.2 MAINTENANCE SERVICES 117
    • 7.2.3 TRAINING SERVICES 117
    • 7.2.4 CALIBRATION SERVICES 117
    • 7.2.5 COMPLIANCE SERVICES 117
    • 7.2.6 TURNKEY SERVICES 117
    • 7.2.7 SCALABLE AUTOMATION SERVICES 117
    • 7.2.8 HARDWARE CUSTOMIZATION 117
    • 7.2.9 INSTRUMENT RELOCATION SERVICES 117
    • 7.2.10 PERFORMANCE ASSURANCE SERVICES 118
    • 7.2.11 DESIGN AND DEVELOPMENT SERVICES 118
    • 7.2.12 SUPPLY CHAIN SOLUTIONS 118
    • 7.2.13 NEW PRODUCT INTRODUCTION SERVICES 118
    • 7.2.14 MANUFACTURING SERVICES 118
    • 7.2.15 ENVIRONMENTAL & REGULATION SERVICES 118
    • 7.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING 118
    • 7.2.17 CLINICAL RESEARCH SERVICES 118
    • 7.2.18 CONSULTATIVE SERVICES 118
    • 7.2.19 OTHER SERVICES 119
  • 7.3 PCR 119
    • 7.3.1 INSTRUMENT REPAIR SERVICES 120
    • 7.3.2 MAINTENANCE SERVICES 120
    • 7.3.3 TRAINING SERVICES 121
    • 7.3.4 CALIBRATION SERVICES 121
    • 7.3.5 COMPLIANCE SERVICES 121
    • 7.3.6 TURNKEY SERVICES 121
    • 7.3.7 SCALABLE AUTOMATION SERVICES 121
    • 7.3.8 HARDWARE CUSTOMIZATION 121
    • 7.3.9 INSTRUMENT RELOCATION SERVICES 121
    • 7.3.10 PERFORMANCE ASSURANCE SERVICES 121
    • 7.3.11 DESIGN AND DEVELOPMENT SERVICES 121
    • 7.3.12 SUPPLY CHAIN SOLUTIONS 122
    • 7.3.13 NEW PRODUCT INTRODUCTION SERVICES 122
    • 7.3.14 MANUFACTURING SERVICES 122
    • 7.3.15 ENVIRONMENTAL AND REGULATION SERVICES 122
    • 7.3.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING 122
    • 7.3.17 CLINICAL RESEARCH SERVICES 122
    • 7.3.18 CONSULTATIVE SERVICES 122
    • 7.3.19 OTHER SERVICES 122
  • 7.4 NEXT GENERATION SEQUENCING 122
    • 7.4.1 INSTRUMENT REPAIR SERVICES 124
    • 7.4.2 MAINTENANCE SERVICES 124
    • 7.4.3 TRAINING SERVICES 125
    • 7.4.4 CALIBRATION SERVICES 125
    • 7.4.5 COMPLIANCE SERVICES 125
    • 7.4.6 TURNKEY SERVICES 125
    • 7.4.7 SCALABLE AUTOMATION SERVICES 125
    • 7.4.8 HARDWARE CUSTOMIZATION 125
    • 7.4.9 INSTRUMENT RELOCATION SERVICES 125
    • 7.4.10 PERFORMANCE ASSURANCE SERVICES 125
    • 7.4.11 DESIGN AND DEVELOPMENT SERVICES 125
    • 7.4.12 SUPPLY CHAIN SOLUTIONS 125
    • 7.4.13 NEW PRODUCT INTRODUCTION SERVICES 126
    • 7.4.14 MANUFACTURING SERVICES 126
    • 7.4.15 ENVIRONMENTAL AND REGULATION SERVICES 126
    • 7.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING 126
    • 7.4.17 CLINICAL RESEARCH SERVICES 126
    • 7.4.18 CONSULTATIVE SERVICES 126
    • 7.4.19 OTHER SERVICES 126
  • 7.5 OTHER TECHNOLOGIES 126

8 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER 128

  • 8.1 OVERVIEW 129
  • 8.2 HOSPITALS 131
    • 8.2.1 INSTRUMENT REPAIR SERVICES 134
    • 8.2.2 MAINTENANCE SERVICES 134
    • 8.2.3 TRAINING SERVICES 134
    • 8.2.4 CALIBRATION SERVICES 134
    • 8.2.5 COMPLIANCE SERVICES 134
    • 8.2.6 TURNKEY SERVICES 134
    • 8.2.7 SCALABLE AUTOMATION SERVICES 134
    • 8.2.8 HARDWARE CUSTOMIZATION 134
    • 8.2.9 INSTRUMENT RELOCATION SERVICES 134
    • 8.2.10 PERFORMANCE ASSURANCE SERVICES 135
    • 8.2.11 DESIGN AND DEVELOPMENT SERVICES 135
    • 8.2.12 SUPPLY CHAIN SOLUTIONS 135
    • 8.2.13 NEW PRODUCT INTRODUCTION SERVICES 135
    • 8.2.14 MANUFACTURING SERVICES 135
    • 8.2.15 ENVIRONMENTAL AND REGULATORY SERVICES 135
    • 8.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION AND AUDITING 135
    • 8.2.17 CLINICAL RESEARCH SERVICES 135
    • 8.2.18 CONSULTATIVE SERVICES 135
    • 8.2.19 OTHER SERVICES 136
  • 8.3 DIAGNOSTIC CENTERS 136
    • 8.3.1 CLINICAL LABORATORIES 137
      • 8.3.1.1 INSTRUMENT REPAIR SERVICES 139
      • 8.3.1.2 Maintenance services 139
      • 8.3.1.3 Training SERVICES 139
      • 8.3.1.4 CALIBRATION SERVICES 139
      • 8.3.1.5 COMPLIANCE SERVICES 139
      • 8.3.1.6 TURNKEY SERVICES 139
      • 8.3.1.7 SCALABLE AUTOMATION SERVICES 139
      • 8.3.1.8 HARDWARE CUSTOMIZATION 139
      • 8.3.1.9 INSTRUMENT RELOCATION SERVICES 139
      • 8.3.1.10 PERFORMANCE Assurance SERVICES 140
      • 8.3.1.11 DESIGN and DEVELOPMENT SERVICES 140
      • 8.3.1.12 SUPPLY CHAIN SOLUTIONS 140
      • 8.3.1.13 NEW PRODUCT INTRODUCTION SERVICES 140
      • 8.3.1.14 MANUFACTURING SERVICES 140
      • 8.3.1.15 ENVIRONMENTAL and REGULATory SERVICES 140
      • 8.3.1.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING 140
      • 8.3.1.17 CLINICAL RESEARCH SERVICES 140
      • 8.3.1.18 CONSULTATIVE SERVICES 140
      • 8.3.1.19 Other SERVICES 141
    • 8.3.2 AMBULATORY SURGICAL CENTERS 141
      • 8.3.2.1 INSTRUMENT REPAIR SERVICES 142
      • 8.3.2.2 MAINTENANCE SERVICES 142
      • 8.3.2.3 TRAINING SERVICES 142
      • 8.3.2.4 CALIBRATION SERVICES 142
      • 8.3.2.5 COMPLIANCE SERVICES 142
      • 8.3.2.6 TURNKEY SERVICES 142
      • 8.3.2.7 SCALABLE AUTOMATION SERVICES 143
      • 8.3.2.8 HARDWARE CUSTOMIZATION 143
      • 8.3.2.9 INSTRUMENT RELOCATION SERVICES 143
      • 8.3.2.10 PERFORMANCE Assurance SERVICES 143
      • 8.3.2.11 DESIGN and DEVELOPMENT SERVICES 143
      • 8.3.2.12 SUPPLY CHAIN SOLUTIONS 143
      • 8.3.2.13 NEW PRODUCT INTRODUCTION SERVICES 143
      • 8.3.2.14 MANUFACTURING SERVICES 143
      • 8.3.2.15 ENVIRONMENTAL AND REGULATORY SERVICES 143
      • 8.3.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING 144
      • 8.3.2.17 CLINICAL RESEARCH SERVICES 144
      • 8.3.2.18 CONSULTATIVE SERVICES 144
      • 8.3.2.19 OTHER SERVICES 144
  • 8.4 ACADEMIC AND RESEARCH INSTITUTES 144
    • 8.4.1 INSTRUMENT REPAIR SERVICES 147
    • 8.4.2 MAINTENANCE SERVICES 147
    • 8.4.3 TRAINING SERVICES 147
    • 8.4.4 CALIBRATION SERVICES 147
    • 8.4.5 COMPLIANCE SERVICES 147
    • 8.4.6 TURNKEY SERVICES 147
    • 8.4.7 SCALABLE AUTOMATION SERVICES 147
    • 8.4.8 HARDWARE CUSTOMIZATION 147
    • 8.4.9 INSTRUMENT RELOCATION SERVICES 147
    • 8.4.10 PERFORMANCE ASSURANCE SERVICES 148
    • 8.4.11 DESIGN AND DEVELOPMENT SERVICES 148
    • 8.4.12 SUPPLY CHAIN SOLUTIONS 148
    • 8.4.13 NEW PRODUCT INTRODUCTION SERVICES 148
    • 8.4.14 MANUFACTURING SERVICES 148
    • 8.4.15 ENVIRONMENTAL AND REGULATORY SERVICES 148
    • 8.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING 148
    • 8.4.17 CLINICAL RESEARCH SERVICES 148
    • 8.4.18 CONSULTATIVE SERVICES 148
    • 8.4.19 OTHER SERVICES 148
  • 8.5 OTHERS 149

9 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION 150

  • 9.1 OVERVIEW 151
  • 9.2 NORTH AMERICA 156
    • 9.2.1 U.S. 170
    • 9.2.2 CANADA 180
    • 9.2.3 MEXICO 190
  • 9.3 EUROPE 200
    • 9.3.1 GERMANY 216
    • 9.3.2 FRANCE 226
    • 9.3.3 U.K. 236
    • 9.3.4 ITALY 246
    • 9.3.5 SPAIN 256
    • 9.3.6 RUSSIA 266
    • 9.3.7 NETHERLANDS 276
    • 9.3.8 SWITZERLAND 286
    • 9.3.9 SWEDEN 296
    • 9.3.10 BELGIUM 306
    • 9.3.11 NORWAY 316
    • 9.3.12 POLAND 326
    • 9.3.13 DENMARK 336
    • 9.3.14 TURKEY 346
    • 9.3.15 FINLAND 356
    • 9.3.16 REST OF EUROPE 366
  • 9.4 ASIA-PACIFIC 367
    • 9.4.1 CHINA 382
    • 9.4.2 JAPAN 392
    • 9.4.3 SOUTH KOREA 402
    • 9.4.4 INDIA 412
    • 9.4.5 AUSTRALIA 422
    • 9.4.6 NEW ZEALAND 432
    • 9.4.7 INDONESIA 442
    • 9.4.8 THAILAND 452
    • 9.4.9 VIETNAM 462
    • 9.4.10 SINGAPORE 472
    • 9.4.11 PHILIPPINES 482
    • 9.4.12 MALAYSIA 492
    • 9.4.13 TAIWAN 502
    • 9.4.14 REST OF ASIA-PACIFIC 512
  • 9.5 SOUTH AMERICA 513
    • 9.5.1 BRAZIL 527
    • 9.5.2 ARGENTINA 537
    • 9.5.3 REST OF SOUTH AMERICA 547
  • 9.6 MIDDLE EAST AND AFRICA 548
    • 9.6.1 SOUTH AFRICA 563
    • 9.6.2 SAUDI ARABIA 573
    • 9.6.3 ISRAEL 583
    • 9.6.4 EGYPT 593
    • 9.6.5 U.A.E. 603
    • 9.6.6 KUWAIT 613
    • 9.6.7 QATAR 623
    • 9.6.8 OMAN 633
    • 9.6.9 BAHRAIN 643
    • 9.6.10 REST OF MIDDLE EAST AND AFRICA 653

10 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY LANDSCAPE 654

  • 10.1 COMPANY SHARE ANALYSIS: GLOBAL 654
  • 10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 655
  • 10.3 COMPANY SHARE ANALYSIS: EUROPE 656
  • 10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 657

11 SWOT ANALYSIS 658

12 COMPANY PROFILE 659

  • 12.1 F.HOFFMANN-LA ROCHE LTD 659
    • 12.1.1 COMPANY SNAPSHOT 659
    • 12.1.2 REVENUE ANALYSIS 659
    • 12.1.3 COMPANY SHARE ANALYSIS 660
    • 12.1.4 SERVICE PORTFOLIO 660
    • 12.1.5 RECENT DEVELOPMENT 660
  • 12.2 DANAHER 661
    • 12.2.1 COMPANY SNAPSHOT 661
    • 12.2.2 REVENUE ANALYSIS 661
    • 12.2.3 COMPANY SHARE ANALYSIS 662
    • 12.2.4 PRODUCT PORTFOLIO 662
    • 12.2.5 RECENT DEVELOPMENT 662
  • 12.3 BIOMERIEUX 663
    • 12.3.1 COMPANY SNAPSHOT 663
    • 12.3.2 REVENUE ANALYSIS 663
    • 12.3.3 COMPANY SHARE ANALYSIS 664
    • 12.3.4 SERVICE PORTFOLIO 664
    • 12.3.5 RECENT DEVELOPMENT 664
  • 12.4 QIAGEN 665
    • 12.4.1 COMPANY SNAPSHOT 665
    • 12.4.2 REVENUE ANALYSIS 665
    • 12.4.3 COMPANY SHARE ANALYSIS 666
    • 12.4.4 SERVICE PORTFOLIO 666
    • 12.4.5 RECENT DEVELOPMENT 666
  • 12.5 THERMO FISHER SCIENTIFIC 667
    • 12.5.1 COMPANY SNAPSHOT 667
    • 12.5.2 REVENUE ANALYSIS 668
    • 12.5.3 COMPANY SHARE ANALYSIS 668
    • 12.5.4 SERVICE PORTFOLIO 669
    • 12.5.5 RECENT DEVELOPMENT 669
  • 12.6 ABBOTT 670
    • 12.6.1 COMPANY SNAPSHOT 670
    • 12.6.2 REVENUE ANALYSIS 670
    • 12.6.3 SERVICE PORTFOLIO 671
    • 12.6.4 RECENT DEVELOPMENT 671
  • 12.7 BIO-RAD LABORATORIES, INC 672
    • 12.7.1 COMPANY SNAPSHOT 672
    • 12.7.2 REVENUE ANALYSIS 672
    • 12.7.3 SERVICE PORTFOLIO 673
    • 12.7.4 RECENT DEVELOPMENTS 673
  • 12.8 DIASORIN 674
    • 12.8.1 COMPANY SNAPSHOT 674
    • 12.8.2 REVENUE ANALYSIS 674
    • 12.8.3 SERVICE PORTFOLIO 675
    • 12.8.4 RECENT DEVELOPMENT 675
  • 12.9 HOLOGIC, INC 676
    • 12.9.1 COMPANY SNAPSHOT 676
    • 12.9.2 REVENUE ANALYSIS 676
    • 12.9.3 SERVICE PORTFOLIO 677
    • 12.9.4 RECENT DEVELOPMENT 677

13 QUESTIONNAIRE 678

14 RELATED REPORTS 681

LIST OF FIGURES

  • FIGURE 1 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION 62
  • FIGURE 2 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: DATA TRIANGULATION 65
  • FIGURE 3 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: DROC ANALYSIS 66
  • FIGURE 4 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 67
  • FIGURE 5 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY RESEARCH ANALYSIS 67
  • FIGURE 6 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: INTERVIEW DEMOGRAPHICS 69
  • FIGURE 7 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: DBMR MARKET POSITION GRID 70
  • FIGURE 8 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: MARKET END USER COVERAGE GRID 71
  • FIGURE 9 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: VENDOR SHARE ANALYSIS 72
  • FIGURE 10 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION 75
  • FIGURE 11 THE RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030 76
  • FIGURE 12 SERVICE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET IN 2023 AND 2030 76
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 77
  • FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 78
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET 82
  • FIGURE 16 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2022 89
  • FIGURE 17 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2023-2030 (USD THOUSAND) 91
  • FIGURE 18 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, CAGR (2023-2030) 91
  • FIGURE 19 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, LIFELINE CURVE 92
  • FIGURE 20 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2022 112
  • FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND) 113
  • FIGURE 22 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, CAGR (2023-2030) 113
  • FIGURE 23 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET : BY TECHNOLOGY, LIFELINE CURVE 114
  • FIGURE 24 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2022 129
  • FIGURE 25 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2023-2030 (USD THOUSAND) 130
  • FIGURE 26 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, CAGR (2023-2030) 130
  • FIGURE 27 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET : BY END USER, LIFELINE CURVE 131
  • FIGURE 28 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022) 152
  • FIGURE 29 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY REGION (2022) 153
  • FIGURE 30 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY REGION (2023 & 2030) 153
  • FIGURE 31 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY REGION (2022 & 2030) 154
  • FIGURE 32 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SERVICE TYPE (2023 -2030) 154
  • FIGURE 33 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022) 157
  • FIGURE 34 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022) 158
  • FIGURE 35 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030) 158
  • FIGURE 36 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030) 159
  • FIGURE 37 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SERVICE TYPE (2023-2030) 159
  • FIGURE 38 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022) 201
  • FIGURE 39 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022) 202
  • FIGURE 40 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030) 202
  • FIGURE 41 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030) 203
  • FIGURE 42 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SERVICE TYPE (2023-2030) 204
  • FIGURE 43 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022) 368
  • FIGURE 44 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022) 369
  • FIGURE 45 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030) 369
  • FIGURE 46 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030) 370
  • FIGURE 47 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SERVICES MARKET: SERVICE TYPE (2023-2030) 370
  • FIGURE 48 SOUTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SNAPSHOT (2022) 514
  • FIGURE 49 SOUTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022) 515
  • FIGURE 50 SOUTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030) 515
  • FIGURE 51 SOUTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030) 516
  • FIGURE 52 SOUTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SERVICE TYPE (2023-2030) 516
  • FIGURE 53 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022) 549
  • FIGURE 54 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022) 550
  • FIGURE 55 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030) 550
  • FIGURE 56 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030) 551
  • FIGURE 57 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SERVICE TYPE (2023-2030) 551
  • FIGURE 58 GLOBAL MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%) 654
  • FIGURE 59 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%) 655
  • FIGURE 60 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%) 656
  • FIGURE 61 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%) 657